View Clinical Trial (Medical Research Study)
Comparison of Immune Response in Normal Volunteers and Patients With Helminth Infections - NCT00004996-20892(Clinical Trial 112653)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Bethesda |
|
State:
|
|
MD |
| Zip Code: |
|
20892 |
| Conditions: |
|
Healthy - Helminthiasis |
| Purpose: |
|
This study will compare the structure, chemical composition and other characteristics of
skin and blood in people with and without parasitic infections. Cell samples will be taken
from blisters produced by suction blistering. This study may provide new information about
the interactions between parasites and the immune system that could lead to better
treatments for these infections.
Normal volunteers and patients with acute helminth (a type of parasite) infections aged 18
years older may be eligible for this study. Following a medical history and physical exam,
participants will undergo suction blistering to provide cells needed for study. A suction
blister device is attached to the skin of the thigh. A heating element in the device heats
the skin to speed blister formation. (This will feel only a slightly warm.) The device is
removed after about two hours, when the blisters have formed. The blister tops are removed
with sterile scissors. The blistered areas are then treated with special dressings to
promote healing and the participant is discharged with further wound care instructions. A
small amount of blood (around four tablespoons) may be drawn to compare chemicals in the
blood with chemicals in the blister fluid. Participants will be contacted by telephone over
the next 72 hours to check on healing. Further follow-up will occur by phone at 6 months and
1 year.
Up to 60 blisters may be produced over a one-year period (in three separate sessions every
six months) with no more than 20 raised per session.
|
| Study summary: |
|
This study will compare the structure, chemical composition and other characteristics of
skin and blood in people with and without parasitic infections. Cell samples will be taken
from blisters produced by suction blistering. This study may provide new information about
the interactions between parasites and the immune system that could lead to better
treatments for these infections.
Normal volunteers and patients with acute helminth (a type of parasite) infections aged 18
years older may be eligible for this study. Following a medical history and physical exam,
participants will undergo suction blistering to provide cells needed for study. A suction
blister device is attached to the skin of the thigh. A heating element in the device heats
the skin to speed blister formation. (This will feel only a slightly warm.) The device is
removed after about two hours, when the blisters have formed. The blister tops are removed
with sterile scissors. The blistered areas are then treated with special dressings to
promote healing and the participant is discharged with further wound care instructions. A
small amount of blood (around four tablespoons) may be drawn to compare chemicals in the
blood with chemicals in the blister fluid. Participants will be contacted by telephone over
the next 72 hours to check on healing. Further follow-up will occur by phone at 6 months and
1 year.
Up to 60 blisters may be produced over a one-year period (in three separate sessions every
six months) with no more than 20 raised per session. |
| Criteria: |
|
- INCLUSION CRITERIA:
1. Between the ages of 18 and 65 years inclusive
2. Access to a primary medical care provider outside of the NIH
3. Able to give informed consent
4. Willingness to have history and physical examination annually
EXCLUSION CRITERIA:
1. History of malignancy or autoimmune disease such as rheumatoid arthritis, vasculitis,
pyoderma gangrenosum
2. Use of systemic corticosteroids within the past month
3. Use of local corticosteroids at the proposed blistering site within the past month
4. Evidence of current acute infection
5. Personal or family history of keloid formation
6. Use of any investigative drugs within the past month
7. History of skin disease within the past one year (e.g. psoriasis, atopic dermatitis)
8. History of diabetes |
|
|
|
| Study is available at: |
|
National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, MD 20892 United States
Primary Contact: Patient Recruitment and Public Liaison Office Email: prpl@mail.cc.nih.gov Phone: (800) 411-1222 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 21, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|